Cadila gets nod for H1N1 vaccine in India

MUMBAI Wed May 12, 2010 12:05pm IST

A man walks past a graffiti about H1N1 influenza on a street side wall in Mumbai September 9, 2009. Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India to market the H1N1 vaccine in the country.  REUTERS/Arko Datta/Files

A man walks past a graffiti about H1N1 influenza on a street side wall in Mumbai September 9, 2009. Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India to market the H1N1 vaccine in the country.

Credit: Reuters/Arko Datta/Files

Related Topics

MUMBAI (Reuters) - Cadila Healthcare Ltd said on Wednesday it has received approval from the Drug Controller General of India (DCGI) to market its H1N1 vaccine in the country.

Used to prevent the infection of swine flu, this egg-based vaccine named 'VaxiFlu-S' will be marketed by Vaxxicare, a division of the company, it said in a statement.

Indian drumakers such as Panacea Biotec and Pune-based unlisted vaccines maker Serum Institute are also close to launch an H1N1 vaccine in the country.

Out of the 139,466 people tested for swine flu symptoms in India since the outbreak of the pandemic in the year 2009, about 23 percent have tested positive for swine flu, Cadila said in a statement.

"The development is positive for the company as India has a huge population of people aged above 60 years and below 15 years," a pharma sector analyst told Reuters over the telephone.

"While Panacea Biotec is looking to sell the vaccine to the government, Cadila has a focus on direct domestic market. This would help company make early in-roads," another analyst said.

The market size for H1N1 vaccine in India in case of high-risk population was about 4-5 million doses, Pankaj Patel, chairman and managing director of Cadila had told Reuters.

Cadila also plans to develop more vaccines against bacterial, viral and protozoal infections at its vaccine technology centre, it said in the statement.

At 11:32 a.m., shares of Cadila Healthcare were trading at 586 rupees, up 1.97 percent in a flat Mumbai market.

(Reporting by Kaustubh Kulkarni, Editing by Ramya Venugopal)

FILED UNDER:
Photo

After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.

OBAMA'S VISIT

Reuters Showcase

Obama Arrives

Obama Arrives

Bear hug with Modi gets Obama's India trip off to warm start.  Full Article | Pictures 

Japanese Hostages

Japanese Hostages

Japan condemns apparent IS execution, demands hostage release.  Full Article 

Ukraine Crisis

Ukraine Crisis

Pro-Russian rebels attack key port; Ukraine says at least 30 dead.  Full Article 

Australian Open

Australian Open

Nadal, Sharapova charge into quarters as top brass shine.  Full Article 

Row over Film

Row over Film

Group says 'American Sniper' film spurs threats against Muslims.  Full Article 

Movie Review

Movie Review

Dolly ki Doli is a breezy watch, writes Shilpa Jamkhandikar.  Full Article | Related Story 

Akshay Kumar's Latest

Akshay Kumar's Latest

"Baby" is a smartly written, well-acted film  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage